Funding for this research was provided by:
Roman Herzog Comprehensive Cancer Centre
Received: 9 June 2019
Accepted: 1 November 2019
First Online: 9 November 2019
Ethics approval and consent to participate
: Ethics approval was obtained by the local ethical review committee of Technical University of Munich at September 05, 2018 (199/18S).Informed consent will be obtained from all participants. Participants will be informed about the General Data Protection Regulation (EU) 2016/679 in the informed consent form.
: Not applicable.
: SEC: Advisory Boards/Advisor: BMS, Astra Zeneca, Roche, Novocure, Daiichi Sankyo, Icotec. Speakers Honoraria: BMS, Astra Zeneca, Roche, Novocure, Daiichi Sankyo, Icotec, Brainlab, Varian, Accuray, Zeiss Meditec, Dr. Sennewald, Elekta, Merck Darmstadt, Medac.CS: CS received a scholarship from Medac GmbH; received a travel grant from NovoCure Ltd.; contributed to a brochure for patients about GBM which was partially sponsored by NovoCure Ltd; received Speakers Honoria from Teva Pharmaceutical Industries Ltd.However, all authors declare that they have no competing interests regarding the materials used or the results presented in this study.